Article
Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptide.
British journal of haematology - 1 Jul 1991
Solera J, Magallón M, Martin-Villar J, Coloma A
Abstract excerpt
We describe a novel point mutation due to C----G transversion at nucleotide 20518 in the exon VI of factor IX gene, resulting in the substitution of glycine (GGG) for arginine (CGG) at position 180 in the polypeptide. This point mutation was found in a patient with a haemophilia BM variant. We designated the altered factor IX produced by this new mutation as factor IXMadrid. This mutation blocks the cleavage site...
Topics
- Amino Acid Sequence
- Base Sequence
- DNA
- DNA Mutational Analysis
- DNA Restriction Enzymes
- DNA, Single-Stranded
- Exons
- Factor IX
- Genes
- Hemophilia B
- Humans
